Related Experiment Video
Updated: Jun 27, 2025

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
High-resolution magnetic resonance vessel wall imaging provides new insights into Moyamoya disease
Hui Yang1,2,3, Guilan Huang1,2, Xi Li4
1Department of Neurology, Clinical Medical School of Jiujiang University, Jiujiang, China.
Abstract:
Moyamoya disease (MMD) is a rare condition that affects the blood vessels of the central nervous system. This cerebrovascular disease is characterized by progressive narrowing and blockage of the internal carotid, middle cerebral, and anterior cerebral arteries, which results in the formation of a compensatory fragile vascular network. Currently, digital subtraction angiography (DSA) is considered the gold standard in diagnosing MMD. However, this diagnostic technique is invasive and may not be suitable for all patients. Hence, non-invasive imaging methods such as computed tomography angiography (CTA) and magnetic resonance angiography (MRA) are often used. However, these methods may have less reliable diagnostic results. Therefore, High-Resolution Magnetic Resonance Vessel Wall Imaging (HR-VWI) has emerged as the most accurate method for observing and analyzing arterial wall structure. It enhances the resolution of arterial walls and enables quantitative and qualitative analysis of plaque, facilitating the identification of atherosclerotic lesions, vascular entrapment, myofibrillar dysplasia, moyamoya vasculopathy, and other related conditions. Consequently, HR-VWI provides a new and more reliable evaluation criterion for diagnosing vascular lesions in patients with Moyamoya disease.
Insights
High-Resolution Magnetic Resonance Vessel Wall Imaging (HR-VWI) offers a more accurate diagnosis for Moyamoya disease (MMD). This advanced technique provides superior visualization of arterial walls compared to traditional methods like DSA, CTA, and MRA.
Area of Science:
- Neurology
- Radiology
- Vascular Medicine
Background:
- Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by progressive stenosis of intracranial arteries.
- Current diagnostic standards, including digital subtraction angiography (DSA), are invasive, while computed tomography angiography (CTA) and magnetic resonance angiography (MRA) may lack diagnostic reliability.
- There is a need for accurate, non-invasive imaging techniques to evaluate arterial wall pathology in MMD.
Purpose of the Study:
- To evaluate the efficacy of High-Resolution Magnetic Resonance Vessel Wall Imaging (HR-VWI) in diagnosing Moyamoya disease.
- To compare the diagnostic capabilities of HR-VWI with established imaging modalities for MMD.
Main Methods:
- Utilized High-Resolution Magnetic Resonance Vessel Wall Imaging (HR-VWI) to visualize and analyze the structure of arterial walls.
- Employed quantitative and qualitative analysis of arterial wall features, including plaque characteristics and vascular abnormalities.
- Compared HR-VWI findings with conventional diagnostic methods such as DSA, CTA, and MRA.
Main Results:
- HR-VWI demonstrated enhanced resolution for observing arterial wall structures.
- This technique facilitated detailed analysis of plaque, enabling identification of various vascular pathologies.
- HR-VWI provided more reliable diagnostic information for vascular lesions associated with Moyamoya disease.
Conclusions:
- High-Resolution Magnetic Resonance Vessel Wall Imaging (HR-VWI) is a highly accurate method for evaluating arterial wall integrity in Moyamoya disease.
- HR-VWI offers a superior, non-invasive alternative for diagnosing MMD and related vascular conditions.
- This advanced imaging modality provides a new, reliable criterion for the diagnosis of vascular lesions in MMD patients.
More Related Videos
11:13Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
Published on: May 24, 2021
09:43Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging
Published on: January 10, 2025